Assessment of Discrimination, Bias, and Inclusion in a United States Hematology and Oncology Fellowship Program
Sign Up to like & getrecommendations! Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.33199
Abstract: Key Points Question What are the experiences of trainees with respect to discrimination, bias, and inclusion during hematology and oncology fellowship? Findings In this qualitative study of anonymous hotline interviews with 17 fellows, 100% of… read more here.
Keywords: inclusion; discrimination bias; hematology; hematology oncology ... See more keywords
Community counts: Evolution of a national surveillance system for bleeding disorders
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Hematology"
DOI: 10.1002/ajh.25076
Abstract: Vip Viprakasit , Amr Ajlan, Yesim Aydinok, Basim A. A. Al Ebadi, Hany Dewedar, Ahmed S. Ibrahim, Lamis Ragab, Omar Trad, Ahmed S. Wataify, Lily L. L. Wong, Ali T. Taher Division of Hematology and… read more here.
Keywords: medicine; hematology; hematology oncology; university ... See more keywords
Creating a cancer genomics curriculum for pediatric hematology‐oncology fellows: A national needs assessment
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.3787
Abstract: With the advent of next generation sequencing, tumor and germline genomic testing are increasingly being used in the management of pediatric cancer patients. Despite this increase in testing, many pediatric hematology–oncology (PHO) providers are not… read more here.
Keywords: hematology; pediatric hematology; hematology oncology; creating cancer ... See more keywords
ONGOING PHASE 1/2 STUDY OF INCB050465, A SELECTIVE PI3Kδ INHIBITOR, FOR THE TREATMENT OF PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B‐CELL MALIGNANCIES (CITADEL‐101)
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2438_139
Abstract: 279 ONGOING PHASE 1/2 STUDY OF INCB050465, A SELECTIVE PI3Kδ INHIBITOR, FOR THE TREATMENT OF PATIENTS (PTS) WITH RELAPSED/ REFRACTORY (R/R) B‐CELL MALIGNANCIES (CITADEL‐101) P. Caimi* | R. Ramchandren | T.J. Phillips | M.S. Wertheim… read more here.
Keywords: phase; hematology; hematology oncology; university ... See more keywords
Just-in-Time Teaching (JiTT) Screencasts: a Randomized Controlled Trial of Asynchronous Learning on an Inpatient Hematology-Oncology Teaching Service
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Education"
DOI: 10.1007/s13187-021-02016-z
Abstract: Background The efficacy of just-in-time teaching (JiTT) screencasts for graduate medical education on an inpatient adult hematology-oncology service (HOS) setting is not known. Our preceding pilot data identified six high-yield topics for this setting. The… read more here.
Keywords: hematology; teaching jitt; hematology oncology; time teaching ... See more keywords
Routine HbA1c among hematology and oncology inpatients: Diabetes-status and hospital-outcomes.
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes research and clinical practice"
DOI: 10.1016/j.diabres.2019.05.002
Abstract: AIMS Using routine HbA1c measurement to determine the prevalence of diabetes mellitus (known and previously unrecognized) and their hospital outcomes among hematology and oncology inpatients. METHODS This was a prospective, observational study. Routine automated HbA1c… read more here.
Keywords: unrecognized diabetes; oncology inpatients; hematology; previously unrecognized ... See more keywords
Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic review
Sign Up to like & getrecommendations! Published in 2017 at "Heliyon"
DOI: 10.1016/j.heliyon.2017.e00473
Abstract: Background Vancomycin-resistance in Enterococcus faecium (VRE) poses a major threat in health care settings. It is well known that patients in hematology and oncology departments are especially at risk of nosocomial VRE acquisition. This systematic… read more here.
Keywords: enterococcus faecium; hematology; hematology oncology; review ... See more keywords
Professional challenges for United States hematology/oncology trainees during COVID-19.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer investigation"
DOI: 10.1080/07357907.2023.2199216
Abstract: (95 words)COVID-19 has been devastating for patients with cancer. In this commentary, we chronicle the pandemic's downstream impacts on United States hematology/oncology trainees in terms of professional development and career advancement. These include loss of… read more here.
Keywords: oncology; oncology trainees; states hematology; hematology ... See more keywords
Chlorhexidine gluconate (CHG) foam improves adherence, satisfaction, and maintains central line associated infection rates compared to CHG wipes in pediatric hematology-oncology and bone marrow transplant patients
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Hematology and Oncology"
DOI: 10.1080/08880018.2022.2090644
Abstract: Abstract CHG-based hygiene methods are often a component of daily hygiene bundles to prevent central line-associated blood stream infections (CLABSIs) in pediatric hematology-oncology patients; however, adherence with 2% CHG wipes was inconsistent within our institution,… read more here.
Keywords: oncology; chg foam; hematology; hematology oncology ... See more keywords
#20: Bloodstream Infections in Pediatric Hematology/Oncology Patients: 3 Years’ Experience of a Specialty Pediatrics Hospital in Tuxtla Gutierrez Chiapas. Mexico
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Pediatric Infectious Diseases Society"
DOI: 10.1093/jpids/piaa170.071
Abstract: Bloodstream infections are the major cause of morbidity, increased cost, prolonged hospitalization, and mortality in pediatric patients. During treatment, cancer patients require a central vascular access; however, central venous catheters are an important source of… read more here.
Keywords: pediatric hematology; hematology; hematology oncology; oncology ... See more keywords
Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients
Sign Up to like & getrecommendations! Published in 2017 at "Oncology"
DOI: 10.1159/000464248
Abstract: Introduction: Surveys state a widespread use of complementary and alternative medicine (CAM) in patients with malignant diseases. CAM methods might potentially interfere with the metabolization of tumor-specific therapy. However, there is little communication about CAM… read more here.
Keywords: medicine; cam; hematology; hematology oncology ... See more keywords